Mitchell Ho, PhD

@MitchellHo

Biochemist & Mentor | Engineering Antibodies, Proteins, and Cells | Senior Investigator & Deputy Chief, Laboratory of Molecular Biology, NCI | Views Are My Own

Bethesda, MD scholar.google.com/citations?user… Joined August 2009

175 Following 410 Followers 192 Posts

Latest posts 5

Pinned post

Mitchell Ho, PhD @MitchellHo Apr 11, 2023

It is such an honor and privilege to work with a group of talented and dedicated trainees, colleagues and collaborators @NCIResearchCtr @IRPatNIH to develop new cancer therapeutic targets. @NanLizea @danli_502 @pan_jiajia @gerard_hoeltzel @CachauRaul

Nature Communications @NatureComms Apr 11, 2023

Development and optimization of CAR T cells targeting glypican-1 for pancreatic cancer therapy.
nature.com/articles/s4146… #CancerResearch @natrescancer @MitchellHo @NanLizea @theNCI @NCIResearchCtr @IRPatNIH

View quoted post on X

Mitchell Ho, PhD @MitchellHo Dec 3, 2024

It has been a great day! Thank you for inviting me to meet with wonderful faculty members and students at OSU and give a lecture at the Annual Meeting of the Pelotonia Institute of ImmunoOncology. @OhioStatePIIO @theNCI @NIH @IRPatNIH

Pelotonia Institute for Immuno-Oncology Verified account @OhioStatePIIO Dec 3, 2024

Excited to feature Dr. @MitchellHo @NIH at #PIIO_2024 with his seminar: "Engineering #Antibodies and #TCells to Target #Glypicans in #Cancer". 6th Annual #PIIO Symposium.🧪✨

View quoted post on X

Mitchell Ho, PhD @MitchellHo Dec 3, 2024

Honored to give a lecture at the Annual Meeting of the Pelotonia Institute of ImmunoOncology at Ohio State University @OhioStatePIIO @OSUCCC_James @Zihai @IRPatNIH @theNCI

Zihai Li, MD, PhD @Zihai Dec 3, 2024

Great talk from @MitchellHo @NIH on engineering antibodies and T cells to target glypicans in cancer. @OhioStatePIIO @OSUCCC_James

View quoted post on X

Mitchell Ho, PhD @MitchellHo Oct 19, 2024

Proud to listen to Dr Dan Li @danli_502 present our work on engineering T cells to target GPC3 in HCC at #ILCA24. @NCIResearchCtr @IRPatNIH @NCI_Training

Mitchell Ho, PhD @MitchellHo Oct 18, 2024

Fantastic opening session “Bench To Bedside: Emerging Therapeutic Targets” #ILCA24 by @Valeriechew29 @TimGreten Dr Greten and I discussed basic and clinical research on liver cancer immunotherapy @NCIResearchCtr @IRPatNIH